(Q45388439)

English

Cellular normalization of viral DNA loads on whole blood improves the clinical management of cytomegalovirus or Epstein Barr virus infections in the setting of pre-emptive therapy

scientific article published in January 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Cellular normalization of viral DNA loads on whole blood improves the clinical management of cytomegalovirus or Epstein Barr virus infections in the setting of pre-emptive therapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Epstein–Barr virus

0 references

Cytomegalovirus

0 references

1 reference

based on heuristic

inferred from title

Berthe-Marie Imbert-Marcille

6

object named as

Berthe-Marie Imbert-Marcille

0 references

Elisabeth André-Garnier

4

object named as

Elisabeth André-Garnier

0 references

author name string

Céline Bressollette-Bodin

1

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Marianne Coste-Burel

2

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Bernard Besse

3

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Elisabeth André-Garnier

4

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Virginie Ferre

5

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Berthe-Marie Imbert-Marcille

6

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

publication date

1 January 2009

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Journal of Medical Virology

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

81

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

90-98

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Optimization of quantitative detection of cytomegalovirus DNA in plasma by real-time PCR.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21334

21 January 2018

Real-time PCR in clinical microbiology: applications for routine laboratory testing

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21334

21 January 2018

Assessment of automated DNA extraction coupled with real-time PCR for measuring Epstein-Barr virus load in whole blood, peripheral mononuclear cells and plasma

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21334

21 January 2018

Whole blood real-time quantitative PCR for cytomegalovirus infection follow-up in transplant recipients.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21334

21 January 2018

Quantification of human cytomegalovirus DNA by real-time PCR.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21334

21 January 2018

Quantitative analysis of HCMV DNA load in whole blood of renal transplant patients using real-time PCR assay.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21334

21 January 2018

Quantification of human cytomegalovirus DNA in bone marrow transplant recipients by real-time PCR.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21334

21 January 2018

Comparison of various blood compartments and reporting units for the detection and quantification of Epstein-Barr virus in peripheral blood

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21334

21 January 2018

Quantitative real-time PCR with automated sample preparation for diagnosis and monitoring of cytomegalovirus infection in bone marrow transplant patients.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21334

21 January 2018

Normalized quantification by real-time PCR of Epstein-Barr virus load in patients at risk for posttransplant lymphoproliferative disorders

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21334

21 January 2018

Measurement of human cytomegalovirus loads by quantitative real-time PCR for monitoring clinical intervention in transplant recipients

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21334

21 January 2018

Clinically-based determination of safe DNAemia cutoff levels for preemptive therapy or human cytomegalovirus infections in solid organ and hematopoietic stem cell transplant recipients

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21334

21 January 2018

Quantitation of human cytomegalovirus in recipients of solid organ transplants by real-time quantitative PCR and pp65 antigenemia

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21334

21 January 2018

Automated extraction and quantification of human cytomegalovirus DNA in whole blood by real-time PCR assay

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21334

21 January 2018

Molecular and diagnostic clinical virology in real time

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21334

21 January 2018

The clinical use of various blood compartments for cytomegalovirus (CMV) DNA quantitation in transplant recipients with CMV disease

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21334

21 January 2018

Multiplex, quantitative, real-time PCR assay for cytomegalovirus and human DNA.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21334

21 January 2018

Late-onset cytomegalovirus disease as a significant complication in solid organ transplant recipients receiving antiviral prophylaxis: a call to heed the mounting evidence

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21334

21 January 2018

Efficacy of valganciclovir administered as preemptive therapy for cytomegalovirus disease in liver transplant recipients: impact on viral load and late-onset cytomegalovirus disease

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21334

21 January 2018

Toward standardization of Epstein-Barr virus DNA load monitoring: unfractionated whole blood as preferred clinical specimen.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21334

21 January 2018

Prevention of Epstein-Barr virus-lymphoproliferative disease by molecular monitoring and preemptive rituximab in high-risk patients after allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21334

21 January 2018

Measurement of Epstein-Barr Virus DNA Loads in Whole Blood and Plasma by TaqMan PCR and in Peripheral Blood Lymphocytes by Competitive PCR

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21334

21 January 2018

Preemptive diagnosis and treatment of Epstein-Barr virus-associated post transplant lymphoproliferative disorder after hematopoietic stem cell transplant: an approach in development

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21334

21 January 2018

Identifiers

10.1002/JMV.21334

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45388439&oldid=2076328655"